Literature DB >> 15472075

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Andrew P Weng1, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster.   

Abstract

Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472075     DOI: 10.1126/science.1102160

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1145 in total

1.  Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Authors:  Shiori Saito; Jiro Kikuchi; Daisuke Koyama; Shin Sato; Hiroo Koyama; Naoki Osada; Yoshiaki Kuroda; Koshi Akahane; Takeshi Inukai; Takashi Umehara; Yusuke Furukawa
Journal:  Clin Cancer Res       Date:  2018-12-05       Impact factor: 12.531

Review 2.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

Review 3.  Molecular pathways to CML stem cells.

Authors:  Kristen N Rice; Catriona H M Jamieson
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

4.  Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Giulia Fabbri; Valeria Spina; Marco Fangazio; Francesco Forconi; Roberto Marasca; Luca Laurenti; Alessio Bruscaggin; Michaela Cerri; Sara Monti; Stefania Cresta; Rosella Famà; Lorenzo De Paoli; Pietro Bulian; Valter Gattei; Anna Guarini; Silvia Deaglio; Daniela Capello; Raul Rabadan; Laura Pasqualucci; Riccardo Dalla-Favera; Robin Foà; Gianluca Gaidano
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

5.  An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.

Authors:  Birgit Knoechel; Justine E Roderick; Kaylyn E Williamson; Jiang Zhu; Jens G Lohr; Matthew J Cotton; Shawn M Gillespie; Daniel Fernandez; Manching Ku; Hongfang Wang; Federica Piccioni; Serena J Silver; Mohit Jain; Daniel Pearson; Michael J Kluk; Christopher J Ott; Leonard D Shultz; Michael A Brehm; Dale L Greiner; Alejandro Gutierrez; Kimberly Stegmaier; Andrew L Kung; David E Root; James E Bradner; Jon C Aster; Michelle A Kelliher; Bradley E Bernstein
Journal:  Nat Genet       Date:  2014-03-02       Impact factor: 38.330

6.  Bone's dark side: mutated osteoblasts implicated in leukemia.

Authors:  Amir Schajnovitz; David T Scadden
Journal:  Cell Res       Date:  2014-03-04       Impact factor: 25.617

7.  Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis.

Authors:  I Cortegano; P Melgar-Rojas; L Luna-Zurita; M Siguero-Álvarez; M A R Marcos; M L Gaspar; J L de la Pompa
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 8.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

9.  Discovery of a ZIP7 inhibitor from a Notch pathway screen.

Authors:  Erin Nolin; Sara Gans; Luis Llamas; Somnath Bandyopadhyay; Scott M Brittain; Paula Bernasconi-Elias; Kyle P Carter; Joseph J Loureiro; Jason R Thomas; Markus Schirle; Yi Yang; Ning Guo; Guglielmo Roma; Sven Schuierer; Martin Beibel; Alicia Lindeman; Frederic Sigoillot; Amy Chen; Kevin X Xie; Samuel Ho; John Reece-Hoyes; Wilhelm A Weihofen; Kayla Tyskiewicz; Dominic Hoepfner; Richard I McDonald; Nicolette Guthrie; Abhishek Dogra; Haibing Guo; Jian Shao; Jian Ding; Stephen M Canham; Geoff Boynton; Elizabeth L George; Zhao B Kang; Christophe Antczak; Jeffery A Porter; Owen Wallace; John A Tallarico; Amy E Palmer; Jeremy L Jenkins; Rishi K Jain; Simon M Bushell; Christy J Fryer
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

10.  Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression.

Authors:  Hidetaka Ohnuki; Kan Jiang; Dunrui Wang; Ombretta Salvucci; Hyeongil Kwak; David Sánchez-Martín; Dragan Maric; Giovanna Tosato
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.